---
title: "Novel liquid embolic agent meets primary feasibility and safety endpoints in EMBO-01 trial"
date: "2024-07-25T07:56:50.000Z"
publishedDate: "25 juillet 2024"
summary: "Arsenal Medical has announced that NeoCast—a first-of-its-kind, shear-responsive liquid embolic material designed for deep distal penetration—met its primary feasibility and safety endpoints in the open-label, multicentre, prospective EMBO-01 clinical trial. These data were presented earlier today at the 2024 Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA)."
importance: ""
sourceUrl: "https://interventionalnews.com/novel-liquid-embolic-agent-meets-primary-feasibility-and-safety-endpoints-in-embo-01-trial/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2024-07-25-novel-liquid-embolic-agent-meets-primary-feasibility-and-safety-endpoints-in-embo-01-trial"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2024/07/Slater-Arsenal-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/novel-liquid-embolic-agent-meets-primary-feasibility-and-safety-endpoints-in-embo-01-trial/"
---

![Novel liquid embolic agent meets primary feasibility and safety endpoints in EMBO-01 trial](https://interventionalnews.com/wp-content/uploads/sites/13/2024/07/Slater-Arsenal-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/novel-liquid-embolic-agent-meets-primary-feasibility-and-safety-endpoints-in-embo-01-trial/*

## L’essentiel

Arsenal Medical has announced that NeoCast—a first-of-its-kind, shear-responsive liquid embolic material designed for deep distal penetration—met its primary feasibility and safety endpoints in the open-label, multicentre, prospective EMBO-01 clinical trial. These data were presented earlier today at the 2024 Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA).

## Lien source

https://interventionalnews.com/novel-liquid-embolic-agent-meets-primary-feasibility-and-safety-endpoints-in-embo-01-trial/
